Liver Disease / Hepatitis News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Hepatitis C And Insulin Resistance - Surprising Findings
We have known for several years that Hepatitis C, a common cause of liver cirrhosis and cancer, also makes people three to four times more likely to develop Type 2 diabetes. In studying the insulin resistance of 29 people with Hepatitis C, Australian researchers have confirmed that they have high insulin resistance, a precursor to diabetes...
Link Between Hepatitis C And Insulin Resistance Surprises Scientists
Scientists in Australia found that when they studied insulin resistance in people with Hepatitis C little or none of it was in the liver and nearly all the insulin resistance occured in muscle, which surprised them because Hepatitis C is a liver disease that not only leads to cirrhosis and cancer, but also makes people three to four times more likely to develop Type 2 diabetes...
Novel Criteria To Differentiate Fibrosis From Steatohepatitis
Alcoholic liver disease (ALD) is the most common cause of liver cirrhosis in the Western world. Liver biopsy is currently considered the gold standard for assessing hepatic fibrosis or cirrhosis in these patients. However, it is an invasive procedure, with rare but potentially life-threatening complications and its accuracy is limited due to sampling error...
Groundbreaking Research To Find Vaccine For Hepatitis C
Researchers at the South West Liver Unit, based at Plymouth Hospitals NHS Trust and supported by the Peninsula Medical School, are working to save more lives and improve the health of Hepatitis C sufferers around the world by developing a vaccine for the disease...
Post-Op Liver Cancer Complications More Frequent At Low-Volume Hospitals
The frequency of post-operative complications following surgery for liver cancer is associated with a hospital having a low volume of liver surgery. Investigators at The Cancer Institute of New Jersey (CINJ) are presenting that finding at the 63rd Annual Society of Surgical Oncology Symposium taking place this week in St. Louis...
U.S. Doctors Sanction Transplant Criteria For Liver Cancer Patients
Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers...
1.3m Pounds Plan To Reduce Hepatitis In Wales
Health Minister Edwina Hart approved a plan to tackle blood borne hepatitis. A total of £1.37 million of Welsh Assembly Government funding has been allocated to deliver the plan, developed by Public Health Wales...
Method Identified To Help Reduce Fat In The Blood
Over 60 per cent of Canadians are classified as overweight or obese. This epidemic is a concern for experts around the world. One of the major problems is high levels of lipids in the blood, which can lead to cardiovascular disease, fatty liver disease and Type 2 diabetes. But a University of Alberta researcher has taken a major step in protecting people against these diseases...
Abbott And Enanta Announce Advancement Of Hepatitis C Collaboration
Abbott (NYSE: ABT) and Enanta Pharmaceuticals announced the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. The trial will evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration, and polymerase inhibitors ABT-333 and ABT-072 currently being developed exclusively by Abbott...
Acculis Breakthrough Liver Cancer Treatment Gets Green Light
Acculis Limited today announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised. The device is a single high power high frequency 2...
Ghrelin Mitigates Liver Fibrosis In Animal Models; Regulates Human Fibrosis
Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models...
Targeted Delivery Of Losartan Reduces Liver Inflammation And Scarring
A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity...
Celsion Plans To Launch Phase II Program To Study ThermoDox(R) In Combination With RFA For Colorectal Liver Metastases
Celsion Corporation (Nasdaq: CLSN) announced that it will initiate a Randomized Phase II Study of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Radiofrequency Ablation (RFA) for Colorectal Liver Metastases (CRLM). Dr. Steven K...
Reliable Biomarkers Needed For Early Detection Of Liver Cancer
While biomarkers are needed to complement ultrasound in the early detection of hepatocellular carcinoma (HCC; liver cancer), neither des-gamma-carboxy prothrombin (DCP) nor the most widely used biomarker, alpha fetoprotein (AFP), is optimal, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute...
What Is Alcoholic Liver Disease? What Is Alcoholic Hepatitis?
Alcoholic liver disease, also called alcoholic hepatitis, refers to a range of conditions and related symptoms that develop when the liver becomes damaged due to excessive intake of alcohol. While distinct from cirrhosis, alcoholic hepatitis is regarded as the earliest stage of alcoholic liver disease...
More Reliable Biomarkers Needed For Liver Cancer Detection
Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month's Gastroenterology. Two biomarkers used to complement ultrasound in the early detection of hepatocellular carcinoma, or liver cancer, are not ideal, according to Anna S. Lok, M.D...
Light Sciences Oncology Meets A Major Milestone In Aptocine Development With Target Enrollment In Phase 3 MCRC Trial
Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocineâ„¢ (talaporfin sodium) for treatment of solid tumors. LSO's global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites...
Hepatitis B And C Remain Public Health Issue--Up To 5.3 Million Americans Infected
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern...
Ocera Therapeutics Completes Phase 2B Enrollment In The ASTUTE Trial
Ocera Therapeutics, Inc. announced that the ASTUTE Study (AST-120 Used to Treat Hepatic Encephalopathy) has completed enrollment for its Phase 2B study ahead of schedule, with data expected mid 2010...
A New Model For The Treatment Of Liver Disease: A Mouse With A Human Liver
How do you study - and try to cure in the laboratory - an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver...
The Mouse With A Human Liver: A New Model For The Treatment Of Liver Disease
How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver...
Histostem Participates In Clinical Trials Demonstrating The Effective Use Of Its Proprietary Stem Cells In The Treatment Of Cirrhosis Of The Liver
AmStem Corporation (OTCBB: SCII) announced that Histostem Ltd. of South Korea ("Histostem"), has participated in a successful preclinical study of the use of its proprietary Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells (HMSCs) in the treatment of cirrhosis of the liver...
Regulatory Science Update: FDA And International Serious Adverse Events Consortium Complete Third Data Release
The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs). The data focus on the genetics associated with DILI and SSR and may help researchers to better predict an individual's risk of developing these serious complications...
Mayo Clinic Health Letter: Highlights From The February Issue
Here are highlights from the February issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://www.HealthLetter.MayoClinic.com...
Enzyme Deficiency Protects Hepatitis C Patients From Treatment-Related Anemia
Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
